Merck 3Q Revenues: $10.3 billion (-2%) 3Q Loss: $56.0 million (earnings were $2.2 billion 3Q16) YTD Revenues: $29.7 billion (flat)   YTD Earnings: $3.5 billion (-24%)    Comments: Pharmaceutical sales were down 3% to $9.2 billion in the quarter. Keytruda achieved sales of $1.0 billion, up 194% with new indications launched globally. Januvia sales were down 2% to $1.5 billion primarily due to pricing pressure partially offset by volume growth globally. Gardasil sales were down 22% to $675 mi...